The Peptide CommonsEst. May 2024
Independent. We sell nothing and are affiliated with no manufacturer or pharmacy. Every moderation action is logged in public
Regional · UK & Ireland · continued

MHRA statements, read directly posts 91–102

This is a continuation of a long topic, addressed by post number rather than by page. Start at post 1 · go to the accepted answer.

GE
g.ekstromTL217 Feb 2026#91
two_year_line, post #64: Practical answer on MHRA statements, since the theoretical one is upthread: do the simplest check first, write down the result, and only then decide whether the complicated explanation is needed. It usually is not. Go to post

Picking up post #90: that is the part I would want checked first.

Speaking only to MHRA statements as I have actually seen it, rather than as it is usually described: the effect is real, it is smaller than the thread suggests, and the variance between people is larger than the effect.

28 likes in reply to #64 5mo
B
BBramleyTL3Regular19 Feb 2026 · edited#92
e.verhoeven, post #85: What I want from this MHRA statements thread is the list of things that would need to be true for the claim to hold. If we can write that list, we can check it. Go to post

Anyone quoting an eligibility threshold should say which document it comes from. The thresholds have changed and the old ones are still circulating.

That is one dataset and I would not build a rule on it.

0 likes in reply to #85 5mo
TT
t.tullochTL220 Feb 2026#93

A referral pathway that worked eighteen months ago may not exist now. The archive keeps these posts and they are read as current.

5 likes 5mo
JH
j.habermannTL3Regular22 Feb 2026#94

I had written a reply contradicting post #92 and deleted it. Here is what survived.

Practical note on MHRA statements: write down what you expect before you look. The number of times I have found what I went looking for is higher than chance would allow.

14 likes 5mo
NS
ni.stanescuTL223 Feb 2026#95

Nothing in this subcategory is medical or legal advice, and prescribers reading here consistently say so themselves.

That holds for the case as described. Change the assumptions and it may not.

21 likes 5mo
AR
ambient_reviewTL3Regular25 Feb 2026#96
to.varga, post #4: The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not. I would rather be precise about what I do not know than vague about what I do. Go to post

MHRA is the regulator. Licensed incretin analogues are prescription-only medicines. NHS and private prescribing routes exist with materially different access criteria and costs.

0 likes in reply to #4 5mo
PO
pe.onwukaTL226 Feb 2026#97

Post #94 is right about the mechanism and I think understates the practical bit.

MHRA statements is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says which one is being asked for.

2 likes 5mo
ET
endpoint_traceTL1Member27 Feb 2026#98

Coming back to post #96, because the follow-up matters more than the original answer.

For anyone finding this later: the short answer on MHRA statements is that it depends on one thing, and the rest of the thread is people identifying which thing.

9 likes 5mo
MR
m.ramosTL21 Mar 2026 · edited#99

The most useful contribution is a link to the current official page with the date you accessed it. That survives; a paraphrase does not.

15 likes 5mo
DN
desiccant_notesTL2Member2 Mar 2026#100
b.solberg, post #72: Reading back through, this was answered upthread and I missed it. My fault. Go to post

Where the MHRA statements reasoning breaks down for me is the step from the group result to the individual case. That step is almost never argued for.

30 likes in reply to #72 5mo
ID
integrator_draftTL3Regular4 Mar 2026#101
l.ibarra, post #37: Narrowing post #36, because the general version has more than one answer. The failure mode on MHRA statements is boring rather than dramatic. It is almost always the step everyone assumes was done correctly because it is too simple to get wrong. Go to post

Waiting times are the most variable and least generalisable thing reported here, and they are worth posting anyway with a region and a date.

I would put the burden of proof on the interesting explanation, not the dull one.

0 likes in reply to #37 5mo
YR
y.ramosTL25 Mar 2026#102

Post #98 put the caveat in the right place and I want to underline it.

My position on MHRA statements is current rather than settled. I have revised it once already and I expect to again, so treat it accordingly.

2 likes 5mo

Suggested topics

TopicParticipantsRepliesViewsActivity
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
APSRNVEOVF+10 14 27k 2d
Irish differences from the UK position
Posting this under the heading it deserves: Irish differences from the UK position Everything below is what sits behind that. Trying to establish the boundary conditions on irish differences. The general…
KOLNVPNCH+62 66 993 21mo
Second pass at: Pharmacy supply in the UK and the questions you will be asked
Second pass at: Pharmacy supply in the UK and the questions you will be asked Writing it up because I had to work it out twice and would rather nobody else did. Asking about Pharmacy supply on behalf of the…
DBDATFHKD+46 53 14k 12mo
NHS criteria and how they are applied in practice
NHS criteria and how they are applied in practice — setting out what I have, and where I think it stops being reliable. I was wrong about NHS criteria in a thread last spring and I would like to correct it…
AEUCRVTPAV+37 42 31k 2d
UK access routes, dated and sourced
UK access routes, dated and sourced Writing it up because I had to work it out twice and would rather nobody else did. Regional question, dated June 2026, because everything in this category expires. The…
NROJC 2 5.8k 15mo

Related topics — sharing the tags NHS, MHRA, personal import

TopicParticipantsRepliesViewsActivity
Irish differences from the UK position — what changed since
Irish differences from the UK position — what changed since — setting out what I have, and where I think it stops being reliable. What changes if the standard account of Irish differences is wrong? I ask…
DOFNTIANPM+8 12 782 1d
Second pass at: Reimbursement variation across member states
On the subject in the title: Second pass at: Reimbursement variation across member states Working notes rather than a conclusion. The question about Reimbursement variation across member states that I…
APCDACBRSB+23 28 45k 21mo
Reimbursement variation across member states
Reimbursement variation across member states Writing it up because I had to work it out twice and would rather nobody else did. Asking about reimbursement variation across member states directly, because I…
SFJSREBS+7 11 39k 3mo
Coming back to: Private prescribing in the UK: what is actually involved
Private prescribing in the UK: what is actually involved Writing it up because I had to work it out twice and would rather nobody else did. I would like to know what people here actually do about Private…
FNFLAWCFKB+62 67 2.1k 6mo
Prescription portability between countries — the long version
On the subject in the title: Prescription portability between countries — the long version Working notes rather than a conclusion. A narrow question about Prescription portability between countries,…
HVMRSC 2 182 21h